|
| ||||||||
J Biol Chem, Vol. 274, Issue 7, 3988-3993, February 12,
1999
,
,
,
,
,
,
,
,
andFrom the The serine protease CD26/dipeptidyl-peptidase IV (CD26/DPP IV) and chemokines
are known key players in immunological processes. Surprisingly,
CD26/DPP IV not only removed the expected Gly1-Pro2
dipeptide from the NH2 terminus of macrophage-derived
chemokine (MDC) but subsequently also the
Tyr3-Gly4 dipeptide, generating MDC(5-69). This
second cleavage after a Gly residue demonstrated that the substrate
specificity of this protease is less restricted than anticipated. The
unusual processing of MDC by CD26/DPP IV was confirmed on the
synthetic peptides GPYGANMED (MDC(1-9)) and YGANMED (MDC(3-9)).
Compared with intact MDC(1-69), CD26/DPP IV-processed MDC(5-69) had
reduced chemotactic activity on lymphocytes and monocyte-derived
dendritic cells, showed impaired mobilization of intracellular
Ca2+ through CC chemokine receptor 4 (CCR4), and was unable to
desensitize for MDC-induced Ca2+-responses in CCR4
transfectants. However, MDC(5-69) remained equally chemotactic as
intact MDC(1-69) on monocytes. In contrast to the reduced binding to
lymphocytes and CCR4 transfectants, MDC(5-69) retained its binding
properties to monocytes and its anti-HIV-1 activity. Thus,
NH2-terminal truncation of MDC by CD26/DPP IV has profound
biological consequences and may be an important regulatory mechanism
during the migration of Th2 lymphocytes and dendritic cells to
germinal centers and to sites of inflammation.
Laboratory of Molecular Immunology, and
Laboratory of
Experimental Chemotherapy, Rega Institute for Medical Research, University of
Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium,
** Laboratory of Immunology, Istituto di Ricerche Farmacologiche
Mario Negri, Via Eritrea 62, I-20157 Milan, Italy, 
Laboratory of
Pharmaceutical Chemistry, and §§ Laboratory of Clinical
Biochemistry, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk,
Belgium
This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)
![]() |
J. K. Lim, W. Lu, O. Hartley, and A. L. DeVico N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variant J. Leukoc. Biol., December 1, 2006; 80(6): 1395 - 1404. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
A. Mosoian, A. Teixeira, A. A. High, R. E. Christian, D. F. Hunt, J. Shabanowitz, X. Liu, and M. Klotman Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages. J. Virol., September 1, 2006; 80(18): 9200 - 9206. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
K. Ohnuma, T. Yamochi, M. Uchiyama, K. Nishibashi, S. Iwata, O. Hosono, H. Kawasaki, H. Tanaka, N. H. Dang, and C. Morimoto CD26 Mediates Dissociation of Tollip and IRAK-1 from Caveolin-1 and Induces Upregulation of CD86 on Antigen-Presenting Cells Mol. Cell. Biol., September 1, 2005; 25(17): 7743 - 7757. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
J. K. Lim, J. M. Burns, W. Lu, and A. L. DeVico Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5 J. Leukoc. Biol., August 1, 2005; 78(2): 442 - 452. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
W. A. Weihofen, J. Liu, W. Reutter, W. Saenger, and H. Fan Crystal Structures of HIV-1 Tat-derived Nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) Bound to the Active Site of Dipeptidyl-peptidase IV (CD26) J. Biol. Chem., April 15, 2005; 280(15): 14911 - 14917. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
U. V. Wesley, M. McGroarty, and A. Homoyouni Dipeptidyl Peptidase Inhibits Malignant Phenotype of Prostate Cancer Cells by Blocking Basic Fibroblast Growth Factor Signaling Pathway Cancer Res., February 15, 2005; 65(4): 1325 - 1334. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
R. Bonecchi, M. Locati, E. Galliera, M. Vulcano, M. Sironi, A. M. Fra, M. Gobbi, A. Vecchi, S. Sozzani, B. Haribabu, J. Van Damme, and A. Mantovani Differential Recognition and Scavenging of Native and Truncated Macrophage-Derived Chemokine (Macrophage-Derived Chemokine/CC Chemokine Ligand 22) by the D6 Decoy Receptor J. Immunol., April 15, 2004; 172(8): 4972 - 4976. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
D. M. Conroy, L. A. Jopling, C. M. Lloyd, M. R. Hodge, D. P. Andrew, T. J. Williams, J. E. Pease, and I. Sabroe CCR4 blockade does not inhibit allergic airways inflammation J. Leukoc. Biol., October 1, 2003; 74(4): 558 - 563. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
K. W. Christopherson II, S. Cooper, and H. E. Broxmeyer Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells Blood, June 15, 2003; 101(12): 4680 - 4686. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
K. W. Christopherson II, G. Hangoc, and H. E. Broxmeyer Cell Surface Peptidase CD26/Dipeptidylpeptidase IV Regulates CXCL12/Stromal Cell-Derived Factor-1{alpha}-Mediated Chemotaxis of Human Cord Blood CD34+ Progenitor Cells J. Immunol., December 15, 2002; 169(12): 7000 - 7008. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
L. Agrawal, Z. Vanhorn-Ali, and G. Alkhatib Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs) J. Leukoc. Biol., November 1, 2002; 72(5): 1063 - 1074. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
R. Geiben-Lynn, N. Brown, B. D. Walker, and A. D. Luster Purification of a Modified Form of Bovine Antithrombin III as an HIV-1 CD8+ T-cell Antiviral Factor J. Biol. Chem., October 25, 2002; 277(44): 42352 - 42357. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
E. P. Boonacker, E. A. Wierenga, H. H. Smits, and C. J.F. Van Noorden CD26/DPPIV Signal Transduction Function, but Not Proteolytic Activity, Is Directly Related to Its Expression Level on Human Th1 and Th2 Cell Lines as Detected with Living Cell Cytochemistry J. Histochem. Cytochem., September 1, 2002; 50(9): 1169 - 1177. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
D. D'Ambrosio, C. Albanesi, R. Lang, G. Girolomoni, F. Sinigaglia, and C. Laudanna Quantitative Differences in Chemokine Receptor Engagement Generate Diversity in Integrin-Dependent Lymphocyte Adhesion J. Immunol., September 1, 2002; 169(5): 2303 - 2312. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
E. Guan, J. Wang, G. Roderiquez, and M. A. Norcross Natural Truncation of the Chemokine MIP-1beta /CCL4 Affects Receptor Specificity but Not Anti-HIV-1 Activity J. Biol. Chem., August 23, 2002; 277(35): 32348 - 32352. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
A. Ludwig, F. Schiemann, R. Mentlein, B. Lindner, and E. Brandt Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine J. Leukoc. Biol., July 1, 2002; 72(1): 183 - 191. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
L. A. Jopling, I. Sabroe, D. P. Andrew, T. J. Mitchell, Y. Li, M. R. Hodge, T. J. Williams, and J. E. Pease The Identification, Characterization, and Distribution of Guinea Pig CCR4 and Epitope Mapping of a Blocking Antibody J. Biol. Chem., February 22, 2002; 277(9): 6864 - 6873. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
P. Proost, E. Schutyser, P. Menten, S. Struyf, A. Wuyts, G. Opdenakker, M. Detheux, M. Parmentier, C. Durinx, A.-M. Lambeir, J. Neyts, S. Liekens, P. C. Maudgal, A. Billiau, and J. Van Damme Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties Blood, December 15, 2001; 98(13): 3554 - 3561. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
M. Chiravuri, F. Agarraberes, S. L. Mathieu, H. Lee, and B. T. Huber Vesicular Localization and Characterization of a Novel Post-Proline-Cleaving Aminodipeptidase, Quiescent Cell Proline Dipeptidase J. Immunol., November 15, 2000; 165(10): 5695 - 5702. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
A. Mantovani, P. A. Gray, J. Van Damme, and S. Sozzani Macrophage-derived chemokine (MDC) J. Leukoc. Biol., September 1, 2000; 68(3): 400 - 404. [Abstract] [Full Text] |
||||
|
| |||||
![]() |
P. Proost, P. Menten, S. Struyf, E. Schutyser, I. De Meester, and J. Van Damme Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist Blood, September 1, 2000; 96(5): 1674 - 1680. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
S. A. Hinke, J. A. Pospisilik, H.-U. Demuth, S. Mannhart, K. Kuhn-Wache, T. Hoffmann, E. Nishimura, R. A. Pederson, and C. H. S. McIntosh Dipeptidyl Peptidase IV (DPIV/CD26) Degradation of Glucagon. CHARACTERIZATION OF GLUCAGON DEGRADATION PRODUCTS AND DPIV-RESISTANT ANALOGS J. Biol. Chem., February 11, 2000; 275(6): 3827 - 3834. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
R. Underwood, M. Chiravuri, H. Lee, T. Schmitz, A. K. Kabcenell, K. Yardley, and B. T. Huber Sequence, Purification, and Cloning of an Intracellular Serine Protease, Quiescent Cell Proline Dipeptidase J. Biol. Chem., November 26, 1999; 274(48): 34053 - 34058. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
M. Chiravuri, H. Lee, S. L. Mathieu, and B. T. Huber Homodimerization via a Leucine Zipper Motif Is Required for Enzymatic Activity of Quiescent Cell Proline Dipeptidase J. Biol. Chem., August 25, 2000; 275(35): 26994 - 26999. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
A.-M. Lambeir, P. Proost, C. Durinx, G. Bal, K. Senten, K. Augustyns, S. Scharpe, J. Van Damme, and I. De Meester Kinetic Investigation of Chemokine Truncation by CD26/Dipeptidyl Peptidase IV Reveals a Striking Selectivity within the Chemokine Family J. Biol. Chem., August 3, 2001; 276(32): 29839 - 29845. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | SEARCH RESULT |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |